THERAPEUTIC CLASS

Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances

---

The ongoing outbreak of the recently emerged 2019 novel coronavirus (nCoV), which has seriously threatened global health security, is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. Despite the burden of the disease worldwide, still, no licensed vaccine or any specific drug against 2019‐nCoV is available

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Allergy & Immune System

Specific Detail Info

DOI: 10.1002/jcp.29771

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment